Your session is about to expire
← Back to Search
Cooling Fan Exercise for COPD
N/A
Recruiting
Led By Dennis Jensen, PhD
Research Sponsored by McGill University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre- and post-5 week of exercise training period.
Awards & highlights
Study Summary
This trial is testing if cooling the face with a fan during exercise can help people with cardiopulmonary disease exercise longer & harder.
Who is the study for?
This trial is for adults with cardiopulmonary diseases like COPD or heart failure, who experience breathlessness during exertion and have a BMI between 18.5 and 35. They must be cleared by their doctor to exercise and not have had recent medication changes or hospitalizations.Check my eligibility
What is being tested?
The study tests if using a Honeywell HT-900 fan to blow cool air on the face helps people with cardiopulmonary disease exercise longer and feel less breathless compared to no fan use, during treadmill exercises at set intensities.See study design
What are the potential side effects?
Since this intervention involves non-pharmacological therapy (fan-to-face), side effects are minimal but may include discomfort from the airflow or skin irritation due to prolonged exposure.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ pre- and post-5 week of exercise training period.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre- and post-5 week of exercise training period.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Borg modified 0-10 category ratio scale for breathlessness intensity
Cardiopulmonary exercise testing endurance time
Secondary outcome measures
Baseline Dyspnea Index and Transition Dyspnea Index
COPD Assessment Test
Cardiopulmonary exercise test physiological response (gas exchange)
+5 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Exercise training with Fan-to-faceExperimental Treatment1 Intervention
Participants randomized to the fan-to-face group will perform supervised exercise training with a basic, portable fan (Honeywell HT-900 Turbo Force Air Circulator). The fan will be placed to the front of the treadmill with airflow directed toward the area of the face innervated by the second and third branches of the trigeminal nerve. The airflow speed will be chosen by each participant so that it is most comfortable to them. An anemometer will measure the airflow from the fan.
Group II: Exercise training with no fanActive Control1 Intervention
Participants randomized to the no fan group will perform supervised exercise training with no fan. The exercise duration and intensity titration will follow the same format as the experimental group.
Find a Location
Who is running the clinical trial?
McGill UniversityLead Sponsor
394 Previous Clinical Trials
998,349 Total Patients Enrolled
Dennis Jensen, PhDPrincipal InvestigatorMcGill University
2 Previous Clinical Trials
77 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I cannot exercise or have certain tests due to health issues like recent surgery or coughing up blood.I have not changed my heart or lung medication in the last two weeks.I have been diagnosed with a heart or lung condition.I was hospitalized due to my condition worsening in the last six weeks.
Research Study Groups:
This trial has the following groups:- Group 1: Exercise training with Fan-to-face
- Group 2: Exercise training with no fan
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacant openings for participants in this experiment?
"Clinicaltrials.gov reveals that the initial posting for this clinical trial was on September 1st 2023 and its most recent update occurred on December 5th 2022, indicating it is no longer seeking candidates. Nevertheless, 1162 other studies are currently in need of participants."
Answered by AI
What are the desired outcomes of this research endeavor?
"The primary aim of this intervention is to measure the efficacy, using a modified Borg 0-10 scale (Borg CR10), of an exercise training program on breathlessness intensity. Secondary outcomes being tracked include changes in 'usual' breathlessness (using Multidimensional Dyspnoea Profile), quality of life (Short Form Health Survey SF-36), and anxiety/depressive symptoms (Hospital Anxiety and Depression Scale HADS). These measurements will be taken before and after the intervention period."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger